Engineering tripartite gene editing machinery for highly efficient non-viral targeted genome integration
Non-viral DNA donor templates are commonly used for targeted genomic integration via homologous recombination (HR), with efficiency improved by CRISPR/Cas9 technology. Circular single-stranded DNA (cssDNA) has been used as a genome engineering catalyst (GATALYST) for efficient and safe gene knock-in. Here, we introduce enGager, an enhanced GATALYST associated genome editor system that increases transgene integration efficiency by tethering cssDNA donors to nuclear-localized Cas9 fused with single-stranded DNA binding peptide motifs. This approach further improves targeted integration and expression of reporter genes at multiple genomic loci in various cell types, showing up to 6-fold higher efficiency compared to unfused Cas9, especially for large transgenes in primary cells. Notably, enGager enables efficient integration of a chimeric antigen receptor (CAR) transgene in 33% of primary human T cells, enhancing anti-tumor functionality. This 'tripartite editor with ssDNA optimized genome engineering (TESOGENASE) offers a safer, more efficient alternative to viral vectors for therapeutic gene modification.
Authors
- Richard Shan
- Ishita Majumdar
- Jakob Starzyk
- Danna Lee (ORCID: https://orcid.org/0009-0004-4111-9195)
- Keqiang Xie (ORCID: https://orcid.org/0009-0007-8320-5165)
- Jiahe Li
- Jiao Wang (ORCID: https://orcid.org/0000-0001-7399-5705)
- Shaobo Yang (ORCID: https://orcid.org/0009-0006-5257-6775)
- Hao Wu (ORCID: https://orcid.org/0009-0002-3249-2428)
- Hangu Nam
Institutions
- Northeastern University (US)
- University of Michigan (US)
- Fulcrum Therapeutics (United States) (US)
- H.B. Fuller (United States) (US)
- Michigan Medicine (US)
- Full Circle Research (United States) (US)
- Quintara Biosciences (United States) (US)
Publication Details
- Journal
- Nature Communications
- Published
- 2025-05-16
- DOI
- https://doi.org/10.1038/s41467-025-59790-3
- Citations
- 4
- Primary Topic
- CRISPR and Genetic Engineering
- Type
- article
- Field-Weighted Citation Impact
- 3.22
Funders
- National Science Foundation
- National Institutes of Health
- NIH Office of the Director